Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments.
about
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid LeukemiaMolecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy.
P2860
Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of Relapsed/Refract ...... t Strategies and Developments.
@en
type
label
Management of Relapsed/Refract ...... t Strategies and Developments.
@en
prefLabel
Management of Relapsed/Refract ...... t Strategies and Developments.
@en
P2860
P1433
P1476
Management of Relapsed/Refract ...... nt Strategies and Developments
@en
P2093
Elias J Jabbour
P2860
P2888
P304
P356
10.1007/S40266-015-0285-6
P577
2015-08-01T00:00:00Z